SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation.

Alva, L; Bernasconi, E; Torrecillos, F; Fischer, P; Averna, A; Bange, M; Mostofi, A; Pogosyan, A; Ashkan, K; Muthuraman, M; et al. Alva, L; Bernasconi, E; Torrecillos, F; Fischer, P; Averna, A; Bange, M; Mostofi, A; Pogosyan, A; Ashkan, K; Muthuraman, M; Groppa, S; Pereira, EA; Tan, H; Tinkhauser, G (2023) Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation. Clin Neurophysiol, 152. pp. 43-56. ISSN 1872-8952 https://doi.org/10.1016/j.clinph.2023.04.013
SGUL Authors: Pereira, Erlick Abilio Coelho

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (3MB) | Preview
[img] Microsoft Word (.docx) (Supplementary material) Published Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

OBJECTIVE: Subthalamic nucleus (STN) beta activity (13-30 Hz) is the most accepted biomarker for adaptive deep brain stimulation (aDBS) for Parkinson's disease (PD). We hypothesize that different frequencies within the beta range may exhibit distinct temporal dynamics and, as a consequence, different relationships to motor slowing and adaptive stimulation patterns. We aim to highlight the need for an objective method to determine the aDBS feedback signal. METHODS: STN LFPs were recorded in 15 PD patients at rest and while performing a cued motor task. The impact of beta bursts on motor performance was assessed for different beta candidate frequencies: the individual frequency strongest associated with motor slowing, the individual beta peak frequency, the frequency most modulated by movement execution, as well as the entire-, low- and high beta band. How these candidate frequencies differed in their bursting dynamics and theoretical aDBS stimulation patterns was further investigated. RESULTS: The individual motor slowing frequency often differs from the individual beta peak or beta-related movement-modulation frequency. Minimal deviations from a selected target frequency as feedback signal for aDBS leads to a substantial drop in the burst overlapping and in the alignment of the theoretical onset of stimulation triggers (to ∼ 75% for 1 Hz, to ∼ 40% for 3 Hz deviation). CONCLUSIONS: Clinical-temporal dynamics within the beta frequency range are highly diverse and deviating from a reference biomarker frequency can result in altered adaptive stimulation patterns. SIGNIFICANCE: A clinical-neurophysiological interrogation could be helpful to determine the patient-specific feedback signal for aDBS.

Item Type: Article
Additional Information: © 2023 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: Adaptive deep brain stimulation, Basal Ganglia, Closed-loop DBS, DBS programming, Local field potentials, Parkinson’s disease, 09 Engineering, 11 Medical and Health Sciences, 17 Psychology and Cognitive Sciences, Neurology & Neurosurgery
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Clin Neurophysiol
ISSN: 1872-8952
Language: eng
Dates:
DateEvent
6 June 2023Published
16 May 2023Published Online
18 April 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
PZ00P3_202166Swiss National Science Foundationhttp://dx.doi.org/10.13039/501100001711
MC_UU_00003/2Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/V00655X/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/P012272/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDNational Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
UNSPECIFIEDRosetrees Trusthttp://dx.doi.org/10.13039/501100000833
MR/V00655X/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
Seedcorn2021\100224Stoneygate TrustUNSPECIFIED
PubMed ID: 37285747
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115466
Publisher's version: https://doi.org/10.1016/j.clinph.2023.04.013

Actions (login required)

Edit Item Edit Item